Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb Shareholders Equity (Quarterly) : 22.32B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.32B |
| March 31, 2026 | 20.07B |
| December 31, 2025 | 18.47B |
| September 30, 2025 | 18.55B |
| June 30, 2025 | 17.44B |
| March 31, 2025 | 17.39B |
| December 31, 2024 | 16.34B |
| September 30, 2024 | 17.14B |
| June 30, 2024 | 17.02B |
| March 31, 2024 | 16.49B |
| December 31, 2023 | 29.43B |
| September 30, 2023 | 29.00B |
| June 30, 2023 | 31.97B |
| March 31, 2023 | 31.82B |
| December 31, 2022 | 31.06B |
| September 30, 2022 | 32.67B |
| June 30, 2022 | 32.60B |
| March 31, 2022 | 31.58B |
| December 31, 2021 | 35.95B |
| September 30, 2021 | 37.21B |
| June 30, 2021 | 36.81B |
| March 31, 2021 | 37.60B |
| December 31, 2020 | 37.82B |
| September 30, 2020 | 50.16B |
| June 30, 2020 | 49.09B |
| Date | Value |
|---|---|
| March 31, 2020 | 49.91B |
| December 31, 2019 | 51.60B |
| September 30, 2019 | 17.65B |
| June 30, 2019 | 16.05B |
| March 31, 2019 | 15.22B |
| December 31, 2018 | 14.03B |
| September 30, 2018 | 13.64B |
| June 30, 2018 | 12.32B |
| March 31, 2018 | 12.79B |
| December 31, 2017 | 11.74B |
| September 30, 2017 | 14.78B |
| June 30, 2017 | 14.70B |
| March 31, 2017 | 14.42B |
| December 31, 2016 | 16.18B |
| September 30, 2016 | 15.61B |
| June 30, 2016 | 14.92B |
| March 31, 2016 | 14.39B |
| December 31, 2015 | 14.27B |
| September 30, 2015 | 15.08B |
| June 30, 2015 | 15.12B |
| March 31, 2015 | 15.55B |
| December 31, 2014 | 14.85B |
| September 30, 2014 | 15.14B |
| June 30, 2014 | 15.33B |
| March 31, 2014 | 15.47B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| AstraZeneca PLC | 47.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.63B |
| Total Liabilities (Quarterly) | 65.32B |
| Debt to Equity Ratio | 2.019 |
| Current Ratio | 1.532 |
| Net Debt Paydown Yield | 1.05% |